Original news and analysis on international IP policy
3D printing used to be an expensive product design tool, but it is quickly becoming an affordable and accessible technology. First emerging in the 1980s, the availability of low-cost, high-performance 3D printers has put the technology firmly within reach of consumers. While this provides a number of opportunities for designers and manufacturers, there is also concern around the impact on IP rights, writes Jia Li.
KAMPALA, Uganda -- For a long time, traditional knowledge and traditional cultural expressions were timidly recognised as intellectual efforts worthy of legal protection. Of recent, indigenous peoples, local communities, and some governments have demanded the recognition of traditional forms of creativity and innovation as protectable intellectual property.
In its newly issued objectives for renegotiation of the North American Free Trade Agreement (NAFTA), the Office of the United States Trade Representative (USTR) has put a strong focus on protecting and exploiting intellectual property rights in the digital environment.
The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained.
A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors.
MUNICH -- The German Federal Supreme Court in a decision drawing significant attention on 11 July upheld a temporary compulsory licence granted for the HIV drug Isentress (X ZB 2/17). The antiretroviral drug, based on raltegravir, has been the object of a prolonged court fight between Japanese drug company Shionogi and its US competitor Merck.
An event on 17 July at the United Nations in New York will address the "UN Secretary General's High-Level Panel on Access to Medicines: Advancing Health-Related SDGs through Policy Coherence."
Attracting a World Intellectual Property Organization external office appears to be a critical priority for a number of countries that have put forward their candidacy for four possible new openings. During the WIPO Program and Budget Committee this week, some of those candidates delivered presentations highlighting their most striking assets, such as bridging continents, region, and economic blocs. But discussions could not lead to the chosen winners this week.
A new project that stimulates the development of affordable and effective drug regimens to treat tuberculosis (TB) is catching notice in policy circles.
Access to artificial intelligence, big data, FinTech, eHealth, and digital connectivity are increasingly providing individuals around the world with access to vital resources such as employment opportunities, online banking and healthcare, according to a United Nations report released today.
The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation.
Access to affordable and quality medicines for all is one of the major commitments of the World Health Organization, and its new medicines and health products strategic framework for the next 15 years calls for new research and development (R&D) models, including delinkage of the R&D costs from the price of products, and fair pricing.